Skip to main content
. 2020 Nov 2;40(11):BSR20201643. doi: 10.1042/BSR20201643

Figure 3. CGA reversed the effect of OVA on the serum levels of OVA-IgE, IFN-γ, ROR-γt, and IL-17A.

Figure 3

(A) The serum level of OVA-IgE was measured by ELISA in AR mice treated with different concentrations (low, medium, and high) of CGA or Dex. (B) The serum level of IFN-γ was measured by ELISA in AR mice treated with different concentrations (low, medium, and high) of CGA or Dex. (C) The serum level of ROR-γt was measured by ELISA in AR mice treated with different concentrations (low, medium, and high) of CGA or Dex. (D) The serum level of IL-17A measured by ELISA in AR mice treated with different concentrations (low, medium, and high) of CGA or Dex. **P<0.01, ∧∧∧P or ***P<0.001; ∧ vs. Control; * vs. OVA (L, low concentration of CGA; M, medium concentration of CGA; H, high concentration of CGA).